Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fabbri

Showing results (391-400 of 438) with videos related to

Pageof 44
Sort By:
Cell Death and Differentiation|September 5, 2009
miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cellsR Spizzo, M S Nicoloso, L Lupini, et al.
Respiratory Research|September 3, 2016
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPDLeonardo M Fabbri, Edward M Kerwin, Selwyn Spangenthal, et al.
European Journal of Pharmacology|April 17, 2013
Bradykinin-induced asthmatic fibroblast/myofibroblast activities via bradykinin B2 receptor and different MAPK pathwaysFederica Sabatini, Fabrizio Luppi, Loredana Petecchia, et al.
Thorax|June 25, 2013
Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?Lowie E G W Vanfleteren, Janwillem W H Kocks, Ian S Stone, et al.
American Journal of Respiratory and Critical Care Medicine|August 11, 2012
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryJørgen Vestbo, Suzanne S Hurd, Alvar G Agustí, et al.
European Journal of Internal Medicine|July 9, 2024
Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: The ICSLIFE pragmatic, randomised controlled studyAlberto Papi, Giacomo Forini, Mauro Maniscalco, et al.
BMJ Open Respiratory Research|June 20, 2024
Sex differences in asthma control, lung function and exacerbations: the ATLANTIS studyTessa M Kole, Susan Muiser, Monica Kraft, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2016
Lung Function Abnormalities in Smokers with Ischemic Heart DiseaseFrits M E Franssen, Joan B Soriano, Nicolas Roche, et al.
The Lancet. Respiratory Medicine|September 11, 2023
COPD and multimorbidity: recognising and addressing a syndemic occurrenceLeonardo M Fabbri, Bartolome R Celli, Alvar Agustí, et al.
Toxicology|August 30, 2011
Inter- and intra-laboratory study to determine the reproducibility of toxicogenomics datasetsD J Scott, A S Devonshire, Y A Adeleye, et al.
Pageof 44

Showing results (391-400 of 438) with videos related to

Sort By:
Pageof 44
Cell Death and Differentiation|September 5, 2009
miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cellsR Spizzo, M S Nicoloso, L Lupini, et al.
Respiratory Research|September 3, 2016
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPDLeonardo M Fabbri, Edward M Kerwin, Selwyn Spangenthal, et al.
European Journal of Pharmacology|April 17, 2013
Bradykinin-induced asthmatic fibroblast/myofibroblast activities via bradykinin B2 receptor and different MAPK pathwaysFederica Sabatini, Fabrizio Luppi, Loredana Petecchia, et al.
Thorax|June 25, 2013
Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?Lowie E G W Vanfleteren, Janwillem W H Kocks, Ian S Stone, et al.
American Journal of Respiratory and Critical Care Medicine|August 11, 2012
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryJørgen Vestbo, Suzanne S Hurd, Alvar G Agustí, et al.
European Journal of Internal Medicine|July 9, 2024
Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: The ICSLIFE pragmatic, randomised controlled studyAlberto Papi, Giacomo Forini, Mauro Maniscalco, et al.
BMJ Open Respiratory Research|June 20, 2024
Sex differences in asthma control, lung function and exacerbations: the ATLANTIS studyTessa M Kole, Susan Muiser, Monica Kraft, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2016
Lung Function Abnormalities in Smokers with Ischemic Heart DiseaseFrits M E Franssen, Joan B Soriano, Nicolas Roche, et al.
The Lancet. Respiratory Medicine|September 11, 2023
COPD and multimorbidity: recognising and addressing a syndemic occurrenceLeonardo M Fabbri, Bartolome R Celli, Alvar Agustí, et al.
Toxicology|August 30, 2011
Inter- and intra-laboratory study to determine the reproducibility of toxicogenomics datasetsD J Scott, A S Devonshire, Y A Adeleye, et al.
Pageof 44